Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

NNNN stock hub

Anbio Biotechnology has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NNNNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NNNN

In the news

Latest news · NNNN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/E176.2

P25 14.9P50 23.2P75 38.5

ROE27

P25 -105.6P50 -46.5P75 -3.1

ROIC15.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NNNN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001982708
Company name	Anbio Biotechnology
Country	Germany
Country code	US
Cusip	G0367B105
Employees	27
Enterprise value	$1.1B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Instruments & Supplies
IPO Date	2025-02-19
Isin	KYG0367B1059
Last refreshed	2026-05-10
Market cap	$1.1B
Market cap category	Small-Cap
Price	$25.84
Price currency	USD
Rev Per Employee	320,253.48x
Sector	Healthcare
Sic	2835
Symbol	NNNN
Website	https://www.anbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.56%
EV Earnings	175.26x
EV/EBIT	194.57x
EV/Sales	129.79x
P/B ratio	37.61x
P/E ratio	176.23x
P/S ratio	131.16x
PE Ratio3 Y	310.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	66.7%
Gross margin	87.24%
Gross Profit	$7.5M
Gross Profit Growth	28.17%
Gross Profit Growth Q	111.69%
Gross Profit Growth3 Y	-15.64%
Net Income	$6.4M
Net Income Growth	169.87%
Net Income Growth Years	2%
Net Income Growth3 Y	-13.84%
Pretax Margin	74.06%
Profit Margin	74.06%
Profit Per Employee	$237,165
Profitable Years	4
ROA	14.66
ROCE	19.13
ROE	27.05
ROIC	15.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	296.09%
EPS Growth	161.3
EPS Growth Years	1
Revenue Growth	5.64x
Revenue Growth Q	73.93x
Revenue Growth Years	2x
Revenue Growth3 Y	-28.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.35
Assets	$30.2M
Cash	$11.9M
Current Assets	$30.2M
Current Liabilities	$87,836
Equity	$30.2M
Liabilities	$87,836
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$11.9M
Net Cash By Market Cap	$1.05
Net Cash Growth	22.85%
Net Debt Equity	$-0.39
Tangible Book Value	$30.2M
Tangible Book Value Per Share	$0.69

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	344.3
Net Working Capital	$18.3M
Quick ratio	177.1
Working Capital	$30.2M
Working Capital Turnover	$0.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	295.71%
200-day SMA	31.27
50-day SMA	25.32
50-day SMA vs 200-day SMA	50under200
All Time High	55.65
All Time High Change	-53.57%
All Time High Date	2025-07-15
All Time Low	5.18
All Time Low Change	398.84%
All Time Low Date	2025-02-19
ATR	2.25
Beta1y	2.93
Beta2y	1.31
Ch YTD	-14.07
High	27.18
High52	55.65
High52 Date	2025-07-15
High52ch	-53.57%
Low	25.5
Low52	6.34
Low52 Date	2025-05-08
Low52ch	307.57%
Ma50ch	2.05%
Price vs 200-day SMA	-17.36%
RSI	44.07
RSI Monthly	60.51
RSI Weekly	48.63
Sharpe ratio	1.6x
Sortino ratio	2.84
Total Return	-3.26%
Tr YTD	-14.07
Tr1m	-5.59%
Tr1w	-10.59%
Tr3m	0.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$5.8M
Operating Income Growth	189.1
Operating Income Growth Q	344.8
Operating Income Growth3 Y	-17.3
Operating margin	66.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,691,200%
Float Percent	90.43%
Shares Institutions	0.13%
Shares Out	43,891,200
Shares Qo Q	1.03%
Shares Yo Y	3.27%
Short Float	0.13%
Short Ratio	1.91
Short Shares	0.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	27,057x
Bv Per Share	0.69
Ch1m	-5.59
Ch1w	-10.59
Ch1y	295.7
Ch3m	0.74
Ch6m	51.11
Change	-0.15%
Change From Open	1.33
Close	25.88
Days Gap	-1.47
Dollar Volume	409,253.9
Earnings Date	2026-04-07
Earnings Time	amc
EBIT	$5.8M
EPS	$0.15
F Score	4
Financing CF	6,947,450
Fiscal Year End	December
Founded	2,021
Graham Number	1.50552
Graham Upside	-94.17
Investing CF	-4,202,496
Ipr	416.8
Iprfo	391.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-07
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-07
Lynch Fair Value	$0.73
Lynch Upside	-97.16
Ma150	26.86
Ma150ch	-3.81%
Ma20	27.74
Ma20ch	-6.85%
Net CF	-3,994,121
Next Earnings Date	2026-10-23
Open	25.5
Optionable	No
Position In Range	20.24
Post Close	25.84
Postmarket Change Percent	0.62
Postmarket Price	$26
Price Date	2026-05-08
Ptbv Ratio	37.61
Relative Volume	0.59x
Revenue	8,646,844x
Tr6m	51.11%
Volume	15,838

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NNNN pay a dividend?

Capital-return profile for this ticker.

Performance

NNNN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NNNN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Float: +90.4% of shares outstanding

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NNNN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.1

Neutral momentum band

Price vs 200-day MA

-17.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NNNN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NNNN stock rating?

Anbio Biotechnology is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NNNN analysis?

The full report lives at /stocks/NNNN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NNNN?

The latest report frames NNNN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NNNN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.